The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design

BACKGROUND: Hypoglycaemia, especially nocturnal, remains the main limiting factor of achieving good glycaemic control in type 1 diabetes. The effect of first generation long-acting insulin analogues in reducing nocturnal hypoglycaemia is well documented in patient with type 1 diabetes. The effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Agesen, Rikke Mette, Alibegovic, Amra Ciric, Andersen, Henrik Ullits, Beck-Nielsen, Henning, Gustenhoff, Peter, Hansen, Troels Krarup, Hedetoft, Christoffer, Jensen, Tonny, Juhl, Claus Bogh, Lerche, Susanne Søgaard, Nørgaard, Kirsten, Parving, Hans-Henrik, Tarnow, Lise, Thorsteinsson, Birger, Pedersen-Bjergaard, Ulrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652000/
https://www.ncbi.nlm.nih.gov/pubmed/31337371
http://dx.doi.org/10.1186/s12902-019-0408-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652000/
https://www.ncbi.nlm.nih.gov/pubmed/31337371
http://dx.doi.org/10.1186/s12902-019-0408-x

Ejemplares similares